Bayer’s $9.5 billion bid to acquire Roche’s U.S. drug unit is an ‘absolute disaster’
Bayer’s bid to buy U.K.-based Roche, one of the world’s largest drugmakers, is a “total disaster,” according to a report released Monday.The company is also seeking to take over Pfizer’s drug division.The report, titled “Bayer’s Roche bid to take Pfizer drug unit off the shelf” by the Washington Post’s Paul Farhi, says that the deal…